Brief: Valo Health announces collaboration with Merck KGaA, Darmstadt, Germany
Nov 20 (Reuters) - Merck KGaA MRCG.DE: VALO HEALTH ANNOUNCES COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY TO DISCOVER AND DEVELOP NOVEL TREATMENTS FOR PARKINSON’S DISEASE AND RELATED DISORDERS VALO HEALTH: PARTNERSHIP INCLUDES UPFRONT AND POTENTIAL MILESTONE PAYMENTS TOTALING UP TO OVER 3 BILLION DOLLARS Source text: nBw3bFqKFa Further company coverage: MRCG.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merck KGaA
See all newsUS stocks weekly: AI reality
US stocks weekly: AI reality
Brief: Bio-Techne Co Will Be Required To Pay To Merck KGaA Termination Fee Equal To $230.5 Million If Deal Terminated Under Certain Circumstances - SEC Filing
Press Digest: Financial Times - June 26
US STOCKS-Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook